• Home

  • The Phoenix

    • Proven Results
  • About

  • News

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • Clinical Research
    • Company News
    • Pilot Study
    Search
    Reasons to Invest in Evren’s Groundbreaking Drug-Free Solution to PTSD
    Josh Kelly
    • Mar 28
    • 2 min

    Reasons to Invest in Evren’s Groundbreaking Drug-Free Solution to PTSD

    In the past, mental health has not been taken seriously. As a result, there are limited resources for sufferers of mental illness. Evren...
    18 views0 comments
    Stop Searching, Start Investing: Evren’s StartEngine Launch
    Josh Kelly
    • Mar 23
    • 2 min

    Stop Searching, Start Investing: Evren’s StartEngine Launch

    Gainesville, FL – March 23, 2022– Evren Technologies, Inc., developer of the post-traumatic stress disorder (PTSD) treatment solution...
    26 views0 comments
    Weaver Gaines to Present Namesake Award
    Josh Kelly
    • Dec 9, 2021
    • 1 min

    Weaver Gaines to Present Namesake Award

    Gainesville, FL – December 9, 2021 – BioFlorida’s 2021 Weaver H. Gaines Entrepreneur of the Year Award will be presented by its namesake,...
    28 views0 comments
    Weaver Gaines to Present at 2021 BioFlorida Conference
    Josh Kelly
    • Dec 6, 2021
    • 1 min

    Weaver Gaines to Present at 2021 BioFlorida Conference

    Gainesville, FL – December 6, 2021 – Evren Co-founder and Executive Chairman Weaver Gaines will be presenting at the annual BioFlorida...
    36 views0 comments
    Evren Technologies, Inc. Wins MedTech Innovator’s Best Video Contest
    Josh Kelly
    • Oct 1, 2021
    • 1 min

    Evren Technologies, Inc. Wins MedTech Innovator’s Best Video Contest

    Gainesville, FL – September 29, 2021 – Evren Technologies, Inc. has won the MedTech Innovator Best Video Competition. Five companies were...
    78 views0 comments
    Evren Technologies receives FDA Breakthrough Device Designation for the Phoenix®
    Josh Kelly
    • Jul 22, 2021
    • 2 min

    Evren Technologies receives FDA Breakthrough Device Designation for the Phoenix®

    Transcutaneous Auricular Vagus Nerve Therapy to Treat PTSD Gainesville, FL – July 21, 2021 – Evren Technologies, Inc. announced today...
    710 views0 comments
    MedTech Innovator Selects Evren to Participate in the 2021 Showcase and Accelerator Program
    Josh Kelly
    • Jul 14, 2021
    • 2 min

    MedTech Innovator Selects Evren to Participate in the 2021 Showcase and Accelerator Program

    MedTech Innovator announced today that Evren was among the 50 companies selected for its flagship showcase and accelerator program. Evren...
    86 views0 comments
    Evren Technologies announces appointment of Robert V. House, Ph.D., as new director
    Josh Kelly
    • Jul 14, 2021
    • 2 min

    Evren Technologies announces appointment of Robert V. House, Ph.D., as new director

    Gainesville, FL June 1, 2021 – Evren Technologies, Inc. announced today that Robert V. House, PhD, has been appointed to the Board of...
    89 views0 comments
    THE EVREN TECHNOLOGIES TEAM HAS BEEN SELECTED AS 2021 ROSENMAN INNOVATORS
    Josh Kelly
    • May 11, 2021
    • 2 min

    THE EVREN TECHNOLOGIES TEAM HAS BEEN SELECTED AS 2021 ROSENMAN INNOVATORS

    Gainesville, FL/May 11,2021 – Evren today announced that it was selected to participate in the 2021 Rosenman Innovators cohort, a group...
    107 views0 comments
    Evren Technologies Chosen to Present at the 2021 Bioelectronic Medicine Forum
    Josh Kelly
    • Apr 5, 2021
    • 1 min

    Evren Technologies Chosen to Present at the 2021 Bioelectronic Medicine Forum

    Gainesville, FL – April 1, 2021 – For the third consecutive year, Evren Technologies, Inc. has been selected to present at the 2021...
    59 views0 comments
    Evren Technologies completes Phoenix® Pilot Study with Excellent Results
    Josh Kelly
    • Mar 22, 2021
    • 2 min

    Evren Technologies completes Phoenix® Pilot Study with Excellent Results

    Gainesville, FL – March 22, 2021 – Evren Technologies is pleased to announce the completion of our IRB-approved pilot study using the...
    218 views0 comments
    Evren Announces NIH Notice of Intent to Fund the Phoenix® Laboratory Phase I SBIR
    Josh Kelly
    • Nov 18, 2020
    • 2 min

    Evren Announces NIH Notice of Intent to Fund the Phoenix® Laboratory Phase I SBIR

    Gainesville, FL – November 18, 2020 – We are pleased to announce that on November 18, 2020, the National Institute of Mental Health sent...
    150 views0 comments
    Evren Receives Certificate of Registration for the Mark Phoenix®
    Josh Kelly
    • Nov 10, 2020
    • 1 min

    Evren Receives Certificate of Registration for the Mark Phoenix®

    Gainesville, FL – November 10, 2020 Evren was notified today that its Mark PHOENIX had been issued a U.S. Trademark Registration covering...
    55 views0 comments
    Evren Wins the Harvard Business School Pitch Competition!
    Josh Kelly
    • Oct 18, 2020
    • 1 min

    Evren Wins the Harvard Business School Pitch Competition!

    Evren Technologies was selected the winner of the the Harvard Business School Pitch Competition of 2020, a competition that involved...
    50 views0 comments
    Evren Progresses to Semifinals of BioPitch at the 23rd Annual BioFlorida Conference
    Josh Kelly
    • Oct 13, 2020
    • 1 min

    Evren Progresses to Semifinals of BioPitch at the 23rd Annual BioFlorida Conference

    BioFlorida conducts an annual pitch competition among companies that are developing products in life sciences or health care, including...
    23 views0 comments
    Phoenix Pilot Study Launched
    Josh Kelly
    • Aug 1, 2020
    • 1 min

    Phoenix Pilot Study Launched

    Evren Technologies is pleased to announce the start of our IRB-approved pilot study using the Phoenix™ device to treat Post-traumatic...
    39 views0 comments
    Richard Ferrari joins Evren Technologies Board of Directors
    Josh Kelly
    • Jun 30, 2020
    • 2 min

    Richard Ferrari joins Evren Technologies Board of Directors

    Evren Technologies announced today that Mr. Richard Ferrari, Co-Founder of De Novo Ventures, has joined the board of directors of Evren.
    80 views0 comments
    Evren Technologies Selected as finalists for Startup Challenge’s North Florida Competition
    Josh Kelly
    • Mar 9, 2020
    • 2 min

    Evren Technologies Selected as finalists for Startup Challenge’s North Florida Competition

    Gainesville, FL – March 2, 2020 – The selection committee at Startup Challenge has chosen Evren Technologies, Inc. to pitch in the final...
    89 views0 comments
    Evren Technologies Selected as an Early Stage Mentoring Participant at the SEBIO Conference
    Josh Kelly
    • Oct 28, 2019
    • 2 min

    Evren Technologies Selected as an Early Stage Mentoring Participant at the SEBIO Conference

    Gainesville, FL – October 7, 2019 – Evren Technologies Inc. will compete with 15 other emerging companies in the Early Stage Mentoring...
    87 views0 comments
    Evren Technologies Adds SlideWave To The Product Development Team
    Josh Kelly
    • Oct 9, 2019
    • 2 min

    Evren Technologies Adds SlideWave To The Product Development Team

    Gainesville, FL – September 16, 2019 – Evren Technologies is pleased to announce their partnership with SlideWave, LLC for the design and...
    78 views0 comments
    1
    2
    EVREN-logo-small.png
    • Facebook
    • Twitter
    • LinkedIn

    Evren Technologies, Inc.

    404 SW 140th Terrace, Suite 50

    Newberry, FL 32669

    ​​​

    info@evrenvns.com 

    THIS WEBSITE MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE WEBSITE, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

    © Copyright 2022 Evren Technologies, Inc. All rights reserved.